Clinical trial
Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative…
NCT00488787 · Javelin Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00488787 |
|---|---|
| Title | Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Pilot Study of the Safety and Efficacy of 10 mg, 30 mg, and 50 mg of Transnasal Ketamine Hydrochloride (PMI-100) for the Treatment of Postoperative Dental Pain |
| Lead sponsor | Javelin Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Postoperative |
| Intervention type | Drug |
| Interventions | intranasal ketamine, placebo |
| Enrollment | 40 |
| Start date | Mar 1, 2001 |
| Primary completion | Apr 1, 2001 |
| Completion | Apr 1, 2001 |
| First posted | Jun 20, 2007 |
| Last update posted | Feb 7, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: